81% of Clinical Trial Volunteers Suffer Reactions to CanSino Biologics’ COVID-19 Vaccine | Collective Evolution – July 11, 2020

(Collective Evolution)  What Happened: COVID-19 vaccines have been in production for several months now, and clinical trials have been underway in various countries. One experimental vaccine being developed by CanSino Biologics, Inc. of Tianjin, China, has completed phase 1 of human clinical trials for COVID-19 vaccine (adenovirus type-5 Ad5-nCoV) and involved 108 volunteers, ranging in age from 45–60 years old. →

Read more via 81% of Clinical Trial Volunteers Suffer Reactions to CanSino Biologics’ COVID-19 Vaccine — Collective Evolution